基本信息 产品详情 公司简介 推荐产品
网站主页 TRIM39 Antibody TRIM39抗体
  • TRIM39抗体—艾普蒂
  • TRIM39抗体—艾普蒂
  • TRIM39抗体—艾普蒂

1/3

TRIM39抗体—艾普蒂

Rabbit Polyclonal TRIM39 Antibody
询价 20μl 起订
50μl 起订
100μl 起订
上海 更新日期:2025-05-20

上海切尔齐生物科技有限公司

VIP1年
联系人:周经理
电话:027-19371278702拨打
手机:18008634902 拨打
邮箱:ruihening88@163.com

产品详情:

中文名称:
TRIM39抗体
英文名称:
Rabbit Polyclonal TRIM39 Antibody
品牌:
艾普蒂
产地:
武汉
保存条件:
Stored at -20°C for 4907 year. Avoid repeated freeze / thaw cycles.
产品类别:
抗体
重组:
应用:
WB: IHC-P: IHC-F: ICC/IF: IP:FC:ChIP: ELISA
种属反应性:
Human,Mouse,Rat
宿主:
Rabbit
偶联物:
靶点:
TRIM39

验证与应用

应用及物种
WB咨询技术 Human,Mouse,Rat
IF咨询技术 Human,Mouse,Rat
IHC1/20-1/100 Human,Mouse,Rat
ICC技术咨询 Human,Mouse,Rat
FCM咨询技术 Human,Mouse,Rat
Elisa1/5000-1/10000 Human,Mouse,Rat
   

产品详情

AliasesTFP; RNF23; TRIM39B
WB Predicted band size60 kDa
Host/IsotypeRabbit IgG
Antibody TypePrimary antibody
StorageStore at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.
Species ReactivityHuman, Mouse, Rat
ImmunogenFusion protein of human TRIM39
FormulationPurified antibody in PBS with 0.05% sodium azide and 50% glycerol.

+ +

  •  

     

       Gel: 8%SDS-PAGE, Lysate: 40 μg, Lane: Mouse skeletal muscle tissue lysate, Primary antibody: P09556(TRIM39 Antibody) at dilution 1/200, Secondary antibody: Goat anti rabbit IgG at 1/8000 dilution, Exposure time: 3 seconds    


  •  

     

       The image is immunohistochemistry of paraffin-embedded Human liver cancer tissue using P09556(TRIM39 Antibody) at dilution 1/20. (Original magnification: ×200)    


  •  

     

       The image is immunohistochemistry of paraffin-embedded Human gastric cancer tissue using P09556(TRIM39 Antibody) at dilution 1/20. (Original magnification: ×200)    


           

参考文献

以下是3篇关于TRIM39抗体的参考文献及其简要摘要:

---

1. **"TRIM39 regulates cell cycle progression and DNA damage responses via stabilizing p21"**

- **作者**: Zhao et al.

- **摘要**: 研究利用TRIM39抗体揭示其通过泛素化调控p21蛋白稳定性,影响G1/S期转换及DNA损伤应答,表明TRIM39在细胞周期调控中的关键作用。

2. **"TRIM39 inhibits apoptosis by stabilizing IAPs through ubiquitination pathway"**

- **作者**: Li et al.

- **摘要**: 通过免疫沉淀(使用TRIM39抗体)发现TRIM39与凋亡抑制蛋白(IAPs)相互作用,并通过泛素化修饰维持IAPs稳定性,从而抑制caspase依赖性细胞凋亡。

3. **"TRIM39 deficiency sensitizes cancer cells to chemotherapy via modulating NF-κB signaling"**

- **作者**: Wang et al.

- **摘要**: 研究通过Western blot(TRIM39抗体验证敲除效率)证明TRIM39缺失通过增强NF-κB信号通路促进化疗药物诱导的肿瘤细胞死亡,提示其作为癌症治疗潜在靶点。

---

以上文献展示了TRIM39在细胞周期、凋亡调控及癌症治疗中的分子机制,相关抗体被用于蛋白互作、表达水平检测及功能研究。如需具体DOI或期刊信息,可进一步补充查询。

       

背景信息

TRIM39 (Tripartite Motif-Containing Protein 39) is a member of the TRIM protein family, characterized by conserved RING, B-box, and coiled-coil domains. It functions as an E3 ubiquitin ligase, playing roles in ubiquitination-mediated protein degradation and signaling regulation. TRIM39 is involved in diverse cellular processes, including cell cycle progression, apoptosis, DNA damage response, and immune regulation. Studies suggest it interacts with proteins like CDK1/cyclin B1 to influence mitotic entry and with p53 to modulate apoptosis. Its role in cancer is context-dependent, acting as a tumor suppressor in some contexts by promoting apoptosis or cell cycle arrest, while potentially supporting tumor survival in others through stress adaptation pathways.

TRIM39 antibodies are essential tools for detecting TRIM39 expression in research applications such as Western blotting, immunohistochemistry, and immunofluorescence. They help elucidate TRIM39’s tissue-specific expression patterns, subcellular localization (primarily nuclear), and regulatory mechanisms. Recent interest focuses on its potential as a therapeutic target, particularly in cancers with dysregulated ubiquitination pathways. Commercial TRIM39 antibodies are typically validated for specificity using knockout cell lines or siRNA-mediated knockdown. Researchers should verify antibody cross-reactivity with homologous TRIM family members, as sequence similarities may lead to off-target detection.

       
TRIM39抗体;TRIM39;TRIM39 Antibody;

公司简介

是一家科研、开发、生产和销售为一体的科技型企业,

成立日期 (2年)
注册资本 20万人民币
员工人数 1-10人
年营业额 ¥ 100万以内
经营模式 贸易,工厂,试剂,定制,服务
主营行业 抗体,蛋白组学,细胞生物学

TRIM39抗体相关厂家报价

  • 抗CRF抗体
  • 抗CRF抗体
  • 维百奥(北京)生物科技有限公司 VIP
  • 2025-12-29
  • 询价
内容声明
拨打电话 立即询价